UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome

Neuropharmacology, 1999-12, Vol.38 (12), p.1917-1920

1999

Volltextzugriff (PDF)

Understanding mental retardation in Down's syndrome using trisomy 16 mouse models

Genes, brain and behavior, 2003-06, Vol.2 (3), p.167-178

2003

Volltextzugriff (PDF)

Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome

Neuropharmacology, 1997-11, Vol.36 (11), p.1549-1554

1997

Volltextzugriff (PDF)

Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome

Neuropharmacology, 2005-07, Vol.49 (1), p.122-128

2005

Volltextzugriff (PDF)

5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat

Neuropharmacology, 2004-03, Vol.46 (4), p.504-510

2004

Volltextzugriff (PDF)

Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-Inositol in selected brain regions and peripheral tissues

Neurochemical research, 2000-04, Vol.25 (4), p.431-435

2000

Volltextzugriff (PDF)

Responses to NMDA in cultured hippocampal neurons from trisomy 16 embryonic mice

Neuroscience letters, 1997-09, Vol.232 (3), p.131-134

1997

Volltextzugriff (PDF)

Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment

British journal of pharmacology, 1991-07, Vol.103 (3), p.1669-1676

1991

Volltextzugriff (PDF)

Effect of 6‐cyano‐2,3‐dihydroxy‐7‐nitro‐quinoxaline (CNQX) on dorsal root‐, NMDA‐, kainate‐ and quisqualate‐mediated depolarization of rat motoneurones in vitro

British journal of pharmacology, 1990-08, Vol.100 (4), p.850-854

1990

Volltextzugriff (PDF)

Increased expression of NR2A subunit does not alter NMDA‐evoked responses in cultured fetal trisomy 16 mouse hippocampal neurons

Journal of neurochemistry, 2001-03, Vol.76 (6), p.1663-1669

2001

Volltextzugriff (PDF)

Serotoninergic modulation of excitability in area CA1 of the in vitro rat hippocampus

Neuroscience letters, 1995-10, Vol.199 (3), p.211-214

1995

Volltextzugriff (PDF)

Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: A model of Down syndrome

Journal of comparative neurology (1911), 2006-02, Vol.494 (5), p.815-833

2006

Volltextzugriff (PDF)

Nitrendipine decreases benzodiazepine withdrawal seizures but not the development of benzodiazepine tolerance or withdrawal signs

British journal of pharmacology, 1990-11, Vol.101 (3), p.691-697

1990

Volltextzugriff (PDF)

The effect of centrally acting myorelaxants on NMDA receptor‐mediated synaptic transmission in the immature rat spinal cord in vitro

British journal of pharmacology, 1992-10, Vol.107 (2), p.628-633

1992

Volltextzugriff (PDF)

The effects of central myorelaxants on synaptically‐evoked primary afferent depolarization in the immature rat spinal cord in vitro

British journal of pharmacology, 1994-02, Vol.111 (2), p.497-502

1994

Volltextzugriff (PDF)

Potentiation of synaptic reflexes by D-serine in the rat spinal cord in vitro

European journal of pharmacology, 1991-03, Vol.195 (2), p.241-244

1991

Volltextzugriff (PDF)

The role of 5-HT2A receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro

European journal of pharmacology, 2005-09, Vol.520 (1-3), p.77-85

2005

Volltextzugriff (PDF)

On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models

Brain Research Reviews, 2001-04, Vol.35 (2), p.115-145

2001

Volltextzugriff (PDF)

5-HT 2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat

Neuropharmacology, 2004, Vol.46 (4), p.504-510

2004

Volltextzugriff (PDF)

5-HT sub(2) receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat

Neuropharmacology, 2004-03, Vol.46 (4), p.504-510

2004

Volltextzugriff (PDF)

SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist: In vitro and in vivo neuropharmacology

European neuropsychopharmacology, 2002-10, Vol.12, p.277-277

2002

Volltextzugriff (PDF)

Potentiation of spinal synaptic transmission in vitro by D-serine in the presence of CNQX

European journal of pharmacology, 1990-07, Vol.183 (5), p.1667-1667

1990

Volltextzugriff (PDF)

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1

Nature (London), 2009-06, Vol.459 (7250), p.1126-1130

2009

Volltextzugriff (PDF)

Down syndrome suppression of tumor growth and the role of the calcineurin inhibitor DSCR1

Nature (London), 2009-05, Vol.459 (7250), p.1126-1130

2009

Volltextzugriff (PDF)

The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro

European journal of pharmacology, 2005-09, Vol.520 (1-3), p.77-85

2005

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome

Understanding mental retardation in Down's syndrome using trisomy 16 mouse models

Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome

Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome

5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat

Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-Inositol in selected brain regions and peripheral tissues

Responses to NMDA in cultured hippocampal neurons from trisomy 16 embryonic mice

Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment

Effect of 6‐cyano‐2,3‐dihydroxy‐7‐nitro‐quinoxaline (CNQX) on dorsal root‐, NMDA‐, kainate‐ and quisqualate‐mediated depolarization of rat motoneurones in vitro

Increased expression of NR2A subunit does not alter NMDA‐evoked responses in cultured fetal trisomy 16 mouse hippocampal neurons

Serotoninergic modulation of excitability in area CA1 of the in vitro rat hippocampus

Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: A model of Down syndrome

Nitrendipine decreases benzodiazepine withdrawal seizures but not the development of benzodiazepine tolerance or withdrawal signs

The effect of centrally acting myorelaxants on NMDA receptor‐mediated synaptic transmission in the immature rat spinal cord in vitro

The effects of central myorelaxants on synaptically‐evoked primary afferent depolarization in the immature rat spinal cord in vitro

Potentiation of synaptic reflexes by D-serine in the rat spinal cord in vitro

The role of 5-HT2A receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro

On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models

5-HT 2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat

5-HT sub(2) receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat

SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist: In vitro and in vivo neuropharmacology

Potentiation of spinal synaptic transmission in vitro by D-serine in the presence of CNQX

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1

Down syndrome suppression of tumor growth and the role of the calcineurin inhibitor DSCR1

The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro

Aktive Filter

Suchergebnisse filtern